MIRA INFORM REPORT

 

 

Report Date :

05.09.2011

 

IDENTIFICATION DETAILS

 

Name :

UMA BROTHERS

 

 

Registered Office :

C-110, Bhaveshwar Plaza, 189 Lbs Marg, Ghatkopar (W), Mumbai – 400 086, Maharashtra, India

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

14.07.1975

 

 

Capital Investment / Paid-up Capital :

Rs.4.000 Millions (Estimated)

 

 

IEC No.:

0399053638

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

 MUMU03158B

 

 

PAN No.:

[Permanent Account No.]

ABJPS8671B

 

 

Legal Form :

Sole Proprietory Concern

 

 

Line of Business :

Supplier, Exporter and Importer of Pharma Raw Materials, Bulk Drugs and its Intermediates

 

 

No. of Employees :

6 Approximately

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 16000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established proprietory concern having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The concern can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INFORMATION PARTED BY

 

Name :

Mr. Ashok Shah

Designation :

Proprietor

Contact No.:

91-9820001553

Date :

29.08.2011

 

 

LOCATIONS

 

Registered Office /Warehouse:

C-110, Bhaweshwar Plaza, 186 Lbs Marg, Ghatkopar (W), Mumbai – 400 086, Maharashtra, India

Tel. No.:

91-22-25004510/25004579

Mobile No.:

91-9820001553 (Mr. Ashok Shah)

Fax No.:

91-22-25000015

E-Mail :

umabros@vsnl.com

Website :

www.umabrothers.com

Area :

335sq.ft

Location :

Owned

 

 

SOLE PROPRIETOR

 

Name :

Mr. Ashok Shah

Designation :

Proprietor

Address :

15, Swashrlya, Plot No. 210, Opp.R. N  Narkar  RD., Ghatkopar (E), Mumbai – 400 077, Maharashtra, India

Date of Birth/Age :

55 Years

Qualification :

B.S.C

 

 

BUSINESS DETAILS

 

Line of Business :

Supplier, Exporter and Importer of Pharma Raw Materials, Bulk Drugs and its Intermediates

 

 

Products :

Parmaceutical Raw Materials, APIs, Bulk Drugs and Substances

·         Diphenhydramine Powder

·         Serratiopeptidase Powder

·         Losartan Powder

·         Glibenclamide Powder

·         Amlodipine Powder

 

Pharmaceutical Intermediates

·         N Bromo Succinimide

·         4 C A P

·         5 Cyano Phtalide

 

Pharmaceutical Excipients

·         Sodium Starch Glycolate

·         Cros Carmellose Sodium

·         Poly Ethylene Glycol

·         Poly Sorbate

 

Nutraceutical Ingredients

·         Vitamins

·         Amino Acids

·         Conjugated Linoleic Acid (CLA)

 

Food Additives and Sweeteners

·         Soya Lecithin Powder and Liquid

·         Ascorbic Acid (Vitamin C)

·         Mono Dextrose

·         Sorbitol Powder

 

Veterinary Health Chemicals

·         Oxyclozanide

·         Albendazole

·         Rafoxanide

 

Herbal Extracts

·         Gymnema Sylvestre Extract

·         Garcinia Cambogia Extract

·         Boswellia Serrata Extract

 

Pharmaceutical Formulations

·         Pharmaceutical Products

 

 

Exports :

 

Product :

Pharma Raw Materials, Bulk Drugs and its Intermediates

Countries :
  • Midlde East
  • Canada
  • UK

 

 

Imports :

 

Product :

Raw Materials

Countries :

China

 

 

Terms :

 

Selling :

L/C, Credit (90 days)

 

 

Purchasing :

L/C, Credit (90 days)

 

 

GENERAL INFORMATION

 

Customers :

·         OEM’s

·         Chemical Companies

 

 

No. of Employees :

6 Approximately

 

 

Bankers :
  • Dena Bank, Ghatkopar (East)
  • Corporation Bank

 

 

Facilities :

CC - Rs.3.000 Millions (Dena Bank)

LC – Rs.2.000 Millions (Dena Bank)

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Devang Mehta and Associates

Chartered Accountant

Address :

Mumbai, Maharashtra, India

 

 

CAPITAL STRUCTURE

 

Capital Investment :

 

Owned :

Rs.4.000 Millions (Estimated)

Borrowed :

--

Total :

Rs.4.000 Millions (Estimated)

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

Particulars

 

31.03.2011

31.03.2010

31.03.2009

Sales Turnover (Approximately)

42.100

35.000

25.000

 

The above information has been parted by Mr. Ashok (Proprietor)

 

Note : Sole Proprietory and Partnership concerns are exempted from filing their financials with the Government Authorities or Registry Records.

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Trade Reference :

 

  • Ranbaxy

 

 

CMT REPORT (Corruption, Money Laundering and Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.45.89

UK Pound

1

Rs.74.31

Euro

1

Rs.65.41

 

 

SCORE and RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

>86

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

71-85

56-70

A

Financial and operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

56-70

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

41-55

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

26-40

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

11-25

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

<10

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.